The WVU Heart and Vascular Institute today announced that it is the first center in West Virginia to enroll patients in the RESPONDER-HF trial evaluating the effectiveness of the Corvia Atrial Shunt, an investigational cardiac implant designed to address the frequent hospitalizations and symptoms that limit quality of life in people suffering from heart failure.